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BACKGROUND
• 42,249 opioid overdose deaths nationwide in 2016, a five-fold increase since 1999
• Physicians who receive industry payments prescribe generic drugs at a lower rate
• Industry payments for a drug to a region are associated with higher market share of 
that drug in that region
• 1 in 12 of all physicians and 1 in 5 family practice physicians in the US received an 
opioid-related industry payment between 2013 and 2014
• 93% of opioid-related payments were for food/beverages between 2013 and 2014
• $46 million spent on opioid related payments to physicians between 2013 and 2014
• Opioid-related payments one year predict higher opioid prescribing the next year
METHODS
• Merged 2015 Medicare Part D and Open Payments Data from PA
• Examined association between number of opioid-related payments received by 
individual physicians and their opioid prescribing rate (opioid claims/total claims)
• Physician specialties grouped into primary care, other specialty, pain management
• Aggregated prescribing and payment data to Pennsylvania Dartmouth Hospital 
Atlas of Health Care Hospital Service Areas (HSAs), N=128
• Analyzed relationship between HSA average opioid-related payments and HSA 
average days of opioid filled per physician




= 𝛽0 + 𝛽1𝑃𝑎𝑖𝑛 + 𝛽2𝑂𝑡ℎ𝑒𝑟𝑆𝑝𝑒𝑐𝑖𝑎𝑙𝑡𝑦 + 𝛽3𝑃𝑎𝑦𝑚𝑒𝑛𝑡𝑁𝑢𝑚𝑏𝑒𝑟
Ecological Analysis: Log-Linear Model
ln 𝑎𝑣𝑔 𝐻𝑆𝐴 𝑃𝑟𝑜𝑣𝑖𝑑𝑒𝑟 𝐷𝑎𝑦𝑠 𝐹𝑖𝑙𝑙𝑒𝑑 = 𝛽0 + 𝛽1(𝑎𝑣𝑔 𝐻𝑆𝐴 𝑃𝑟𝑜𝑣𝑖𝑑𝑒𝑟 𝑂𝑝𝑖𝑜𝑖𝑑 𝑃𝑎𝑦𝑚𝑒𝑛𝑡𝑠)
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DISCUSSION & LIMITATIONS
 Opioid-related payments are associated with higher opioid prescribing rate at the 
individual level and the HSA level
 Certain physician specialties receive more payments at a higher monetary value 
than other specialties, and physicians who receive opioid-related payments 
prescribe a higher volume of all drugs
 Administrators and policy makers should consider revising rules related to 
pharmaceutical company marketing tactics
• Limitations
o Suppression of low prescribing rates (derived from fewer than 11 beneficiaries) may 
underestimate the difference between those who did and did not receive industry 
payments due to greater missingness for unpaid physicians than paid physicians
o Cross-sectional analysis: no temporality
o HSAs cross state borders, but we only used PA payment and prescribing data 
(values from some border HSAs may be less reliable)
o This data is derived from Medicare Part D claims, so it only reflects prescribing to 
the population of Pennsylvania Part D beneficiaries
o Direction of association unknown: paid prescribers prescribe more or high volume 
prescribers targeted for marketing?
CORE COMPETENCIES
1A4/1B4/1C4 Uses information technology in accessing, collecting, analyzing, using, 
maintaining, and disseminating data and information, 1B1 Describes factors affecting 
the health of a community, 1B2 Identifies/Determines quantitative and qualitative 
data and information needed for assessing the health of a community, 1A5/1B5
Selects valid and reliable data/Analyzes the validity and reliability of data, 1A9
Describes public health applications of quantitative and qualitative data, 1B9: Analyzes 
quantitative and qualitative data, 1A10/1B10 Uses/Interprets qualitative and 
quantitative data, 1A14: Describes how evidence (e.g., data, findings reported in peer-
reviewed literature) is used in decision making, 3B2 Communicates in writing and 
orally with linguistic and cultural proficiency, 3B4 Suggests/Selects approaches for 
disseminating public health data and information, 3A5/3B5/3C5 Conveys data and 
information to professionals and the public using a variety of approaches, 6A5: 
Recognizes limitations of evidence (e.g., validity, reliability, sample size, bias, 
generalizability), 6B6: Determines limitations of evidence (e.g., validity, reliability, 
sample size, bias, generalizability), 6C6: Explains limitations of evidence (e.g., validity, 
reliability, sample size, bias, generalizability), 6A8/6B9/6C9 Contributes to the 
public health evidence base
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• 40,390 total physicians in the sample, 1,675 received opioid-related payments
• 28,894 with unsuppressed opioid prescribing rate, 1,616 of those received payments
• Primary care physicians who received opioid-related payments prescribed 
approximately three times more of all drugs than the state average
• More than 50% of pain management physicians received an opioid-related payment
• One additional payment to a physician was associated with 4.2% higher opioid-
prescribing rate, with pain management prescribing at the highest rate and primary 
care prescribing at the lowest rate
• One additional payment per physician in an HSA was associated with 79% more 
days of opioid filled on average by each HSA physician
Association Between Opioid-Related Payments and Physician Opioid Prescriber Rate 
DF Chi-Square p
Specialty 2 483191 <.0001
Payment Number 1 131492 <.0001
Specialty 𝐞𝛃 95% CI 𝐞𝛃 SE Wald p LS Means
Other Specialty 2.06 2.05 – 2.06 0.0013 310185 <.0001 8.08%
Pain 9.89 9.81-9.97 0.0042 300758 <.0001 29.70%
Primary Care Ref Ref Ref Ref Ref 4.10%
𝐞𝛃 95% CI 𝐞𝛃 SE Chi-Square p
Payment Number 1.0418 1.0416-1.0420 0.0001 122678 <.0001
Note: DF = Degrees of Freedom, 𝒆𝜷 = Exponentiated Beta, CI = Confidence Interval, SE = Standard Error of the 
Mean, LS Means = Least Square Means for the percent of all Part D claims accounted for by opioids. Chi-Square 
values differ slightly for the Payment Number variable between the top and bottom rows because the top 
reflects maximum likelihood estimates, the bottom Bayesian contrast estimates.
HSA Level Association Between Opioid-Related Payments and Opioid Prescriber Rate
Parameter 𝐞𝛃 95% CI 𝐞𝛃 Chi-Square DF p
Payments per HSA Physician 1.79 1.23-2.61 9.17 1 0.0025
Note: 𝑒𝛽 = Exponentiated Beta Contrast Estimate, CI = Confidence Interval, DF = Degrees of Freedom
